Gerald J. Beck, Ph.D.
Quantitative Health Sciences /JJN3
Telephone: (216)444-9927
Fax: (216)445-2781
beckg@ccf.org
 |
Positions: Full Staff, Biostatistics and Epidemiology, Adjunct Associate Professor, Department of Epidemiology and Biostatistics, Education: |
Key Interests:
Dr. Beck is a full staff member of the Department. His research interests include the design and analysis of clinical trials and prospective studies. The Clinical Trials Design and Analysis Section of the Department which he leads is the Data Coordinating Center (DCC) for several NIDDK supported multicenter clinical trials and prospective studies primarily in the areas of chronic kidney disease and hemodialysis. Currently, he is the Principal Investigator of the DCC for the Frequent Hemodialysis Network (FHN), Dialysis Access Consortium (DAC), and the Hemodialysis Fistula Maturation Consortium (HFMC). In addition, he is the Principal Investigator of the Cleveland Clinic clinical center for NCI supported multicenter clinical trials studying dietary supplements and their relationship with the recurrence of neoplastic large bowel polyps.
Selected Publications:
Dixon BS, Beck GJ, Vazquez MA, et al. for the Dialysis Access Consortium (DAC) Study Group. Effect of dipyridamole plus aspirin on hemodialysis graft patency. N Engl J Med 2009;360:2191-201.
Dember L, Beck G, Allon M, et al. for the Dialysis Access Consortium (DAC) Study Group. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis. J Am Med Assoc 2008;299:2164-71.
Menon V, Wang X, Sarnak MJ, Hunsicker LH, Madero M, Beck GJ, et al.Long-term outcomes in non-diabetic chronic kidney disease. Kid Internat 2008;73:1310-15.
Maurer JR, Ryu J, Beck G, et al. for the NHLBI LAM Registry Study Group. Lung transplantation in the management of patients with LAM: Baseline data from the NHLBI LAM Registry. J Heart Lung Transplant 2007;26:1293-99.
Cole BF, Baron JA, Sandler RS, …., Beck GJ, et al. for the Polyp Prevention Study Group. Folic acid for the prevention of colorectal adenomas. J Am Med Assoc;2007; 297:2351-59.
Suri RS, Garg AX, Chertow GM, Levin NW, Rocco MV, Greene T, Beck GJ, et al. for the Frequent Hemodialysis Network (FHN) Trial Group. The Frequent Hemodialysis Network (FHN) randomized trials: study design. Kid Internat;2007;71:349-59.
Levey AS, Greene T, Sarnak MJ, Wang X, Beck GJ, et al. Effect of dietary protein restriction on the progression of kidney disease: Long-term follow-up of the MDRD Study. Am J Kid Dis;2006;48:879-88.